To provide for a demonstration project to further examine the benefits of providing coverage and payment for items and services necessary to administer intravenous immune globulin (IVIG) in the home, and for other purposes.
USA115th CongressHR-4724| House
| Updated: 12/22/2017
George Holding
Republican Representative
North Carolina
Cosponsors (14)
John Garamendi (Democratic)Leonard Lance (Republican)Patrick Meehan (Republican)André Carson (Democratic)G. K. Butterfield (Democratic)Mike Kelly (Republican)Doris O. Matsui (Democratic)Ryan A. Costello (Republican)Henry Cuellar (Democratic)Diane Black (Republican)Julia Brownley (Democratic)Earl Blumenauer (Democratic)Ileana Ros-Lehtinen (Republican)Lloyd Doggett (Democratic)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Medicare IVIG Access Enhancement Act This bill requires the Centers for Medicare & Medicaid Services to establish a three-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
Congressional oversightDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHome and outpatient careMedicareNeurological disorders
To provide for a demonstration project to further examine the benefits of providing coverage and payment for items and services necessary to administer intravenous immune globulin (IVIG) in the home, and for other purposes.
USA115th CongressHR-4724| House
| Updated: 12/22/2017
Medicare IVIG Access Enhancement Act This bill requires the Centers for Medicare & Medicaid Services to establish a three-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
George Holding
Republican Representative
North Carolina
Cosponsors (14)
John Garamendi (Democratic)Leonard Lance (Republican)Patrick Meehan (Republican)André Carson (Democratic)G. K. Butterfield (Democratic)Mike Kelly (Republican)Doris O. Matsui (Democratic)Ryan A. Costello (Republican)Henry Cuellar (Democratic)Diane Black (Republican)Julia Brownley (Democratic)Earl Blumenauer (Democratic)Ileana Ros-Lehtinen (Republican)Lloyd Doggett (Democratic)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congressional oversightDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHome and outpatient careMedicareNeurological disorders